J. Glenn

发表

Advanced Glycation as a Basis for Understanding Retinal Aging and Noninvasive Risk Prediction

A. Pawlak, J. Glenn, J. Beattie, 2008, Annals of the New York Academy of Sciences.

RAGE Regulates Immune Cell Infiltration and Angiogenesis in Choroidal Neovascularization

Angelika Bierhaus, Heping Xu, J. Glenn, 2014, PloS one.

Effect of ternary phosphate-based glass compositions on osteoblast and osteoblast-like proliferation, differentiation and death in vitro.

J. Glenn, G. Georgiou, J. Knowles, 2007, Acta biomaterialia.

Propionibacterium acnes Wound Contamination at the Time of Spinal Surgery

J. Glenn, S. Patrick, G. McLorinan, 2005, Clinical orthopaedics and related research.

Inhibition of Advanced Glycation and Absence of Galectin-3 Prevent Blood-Retinal Barrier Dysfunction during Short-Term Diabetes

J. Glenn, Alan W. Stitt, D. Hsu, 2007, Experimental diabetes research.

Advanced Glycation End Products (AGEs) accumulate in the Reproductive Tract of Men with Diabetes.

J. Glenn, Alan W. Stitt, A. Atkinson, 2007 .

Distribution of the receptor for advanced glycation end products in the human male reproductive tract: prevalence in men with diabetes mellitus.

J. Glenn, Alan W. Stitt, A. Atkinson, 2007, Human reproduction.

Advanced glycation end product (AGE) accumulation on Bruch's membrane: links to age-related RPE dysfunction.

Keqiang Wu, M. Boulton, J. Glenn, 2009, Investigative ophthalmology & visual science.

Retinal endothelial cell apoptosis stimulates recruitment of endothelial progenitor cells.

T. Curtis, J. Glenn, Alan W. Stitt, 2009, Investigative ophthalmology & visual science.

Advanced glycation of fibronectin impairs vascular repair by endothelial progenitor cells: implications for vasodegeneration in diabetic retinopathy.

T. Curtis, J. Glenn, Alan W. Stitt, 2008, Investigative ophthalmology & visual science.

Propionibacterium acnes Types I and II Represent Phylogenetically Distinct Groups

J. Glenn, D. Persing, M. Tunney, 2005, Journal of Clinical Microbiology.

Lipoprotein-associated phospholipase A2 (Lp-PLA2) as a therapeutic target to prevent retinal vasopermeability during diabetes

Francisco J. López, J. Glenn, Alan W. Stitt, 2016, Proceedings of the National Academy of Sciences.

Differences in mouse models of diabetes mellitus in studies of male reproduction.

J. Glenn, Alan W. Stitt, N. Mcclure, 2010, International journal of andrology.

The role of advanced glycation end products in retinal ageing and disease.

J. Glenn, Alan W. Stitt, 2009, Biochimica et biophysica acta.

Raman spectroscopy of advanced glycation end products (AGEs), possible markers for progressive retinal dysfunction

Anna Pawlak, John J. McGarvey, J. Renwick Beattie, 2008 .

Fundamental consideration of Research: with reference to the AO Research Institute and the AO Foundation

J. Glenn, S. Patrick, A. McDowell, 2017 .

Impaired retinal angiogenesis in diabetes: role of advanced glycation end products and galectin-3.

J. Glenn, Alan W. Stitt, D. Hsu, 2005, Diabetes.

Upregulation of oxidative stress markers in human microvascular endothelial cells by complexes of serum albumin and digestion products of glycated casein

J. Glenn, Alan W. Stitt, P. Deo, 2009, Journal of biochemical and molecular toxicology.

Confocal Raman microscopy can quantify advanced glycation end product (AGE) modifications in Bruch's membrane leading to accurate, nondestructive prediction of ocular aging

M. Boulton, J. Glenn, J. Beattie, 2007, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

Proteomic profiling of human retinal pigment epithelium exposed to an advanced glycation-modified substrate

M. Boulton, J. Glenn, Alan W. Stitt, 2012, Graefe's Archive for Clinical and Experimental Ophthalmology.